nps pharmaceuticals inc
(NPSP:NASDAQ SE Consolidated Large Cap)

Executive Profile*

Background*

Dr. Roger J. Garceau, M.D., FAAP has been the Chief Medical Officer and Executive Vice President of NPS Pharmaceuticals Inc. since December 11, 2008 and January 1, 2013 respectively and served as its Senior Vice President and Senior Vice President of Research & Development from December 11, 2008 to December 31, 2012. Dr. Garceau joined Sanofi-aventis in 2002 where he served as Vice President of the new products group. Dr. Garceau held various positions at Sanofi-aventis ... including Vice President, clinical operations, Interim Head of North American medical and regulatory affairs, and Head of U.S. medical research, where he lead a team of over 200 professionals and oversaw the design and execution of over 50 sponsored studies in five different therapeutic areas. He has over 20 years of broad pharmaceutical industry experience. Prior to his tenure at Sanofi-aventis, Dr. Garceau was 16 years with Pharmacia Corporation in global development and medical affairs where he successfully contributed to a number of marketing applications. Dr. Garceau is a board-certified pediatrician. He is a Fellow of the American Academy of Pediatrics. Dr. Garceau received Bachelor of science in Biology from Fairfield University in Fairfield, Connecticut and his Doctorate of Medicine from the University of Massachusetts Medical School.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
NPSP:US	$14.28 USD	+0.53

COMPETITOR COMPENSATION